Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Advanz Pharma Corp Company

CXRXF
JE00BJVH6L55
A2PYQF

Price

17.06
Today +/-
+0
Today %
+0 %
P

Advanz Pharma Corp stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Advanz Pharma Corp stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Advanz Pharma Corp stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Advanz Pharma Corp stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Advanz Pharma Corp's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Advanz Pharma Corp Stock Price History

DateAdvanz Pharma Corp Price
6/10/202117.06 undefined
6/9/202117.06 undefined

Advanz Pharma Corp Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Advanz Pharma Corp, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Advanz Pharma Corp from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Advanz Pharma Corp’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Advanz Pharma Corp. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Advanz Pharma Corp’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Advanz Pharma Corp’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Advanz Pharma Corp’s growth potential.

Advanz Pharma Corp Revenue, EBIT and net profit per share

DateAdvanz Pharma Corp RevenueAdvanz Pharma Corp EBITAdvanz Pharma Corp Net Income
2021e402.28 M undefined0 undefined-15.51 B undefined
2020525.58 M undefined29.77 M undefined-74.86 M undefined
2019508.32 M undefined23.09 M undefined-196.02 M undefined
2018536.99 M undefined-4.35 M undefined1.47 B undefined
2017626.17 M undefined78 M undefined-1.59 B undefined
2016816.16 M undefined231.22 M undefined-1.32 B undefined
2015394.22 M undefined138.22 M undefined-31.57 M undefined

Advanz Pharma Corp Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2015201620172018201920202021e
394816626536508525402
-107.11-23.28-14.38-5.223.35-23.43
75.8972.7969.4967.3566.1463.43-
2995944353613363330
13823178-423290
35.0328.3112.46-0.754.535.52-
-0.03-1.32-1.591.47-0.2-0.07-15.51
-4,141.9420.91-192.26-113.36-62.2420,852.70
0.120.170.1715.6648.9148.910
-------
Details

Keystats

ⓘ

Revenue and Growth

The Advanz Pharma Corp Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Advanz Pharma Corp is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
201520162017201820192020
           
155.45397.92327.03224.44261.14160.19
193.19182.49146.03115.09109.92115.44
6.1824.860.872.022.053.67
100.6192.8176.7273.9371.1133.13
26.7715.9516.9628.6625.5737.11
482.2714.02567.61444.14469.78449.53
5.055.373.432.5511.818.84
000000
000000
3.962.281.51.150.890.87
824.53707.93244.96232.78224.54254.17
8.7424.532.474.781.511.3
4.83.021.751.391.121.13
5.283.732.321.831.591.58
           
1.271.281.281.921.921.92
23.5649.9552.7655.2859.2262.53
-37.53-1,360.87-2,951.61-1,484.31-1,681.67-1,756.53
-104.29-343.82-294.75-289.31-277.44-213.41
000000
1.16-0.38-1.910.20.020.01
38.6135.0226.3522.2716.2448.11
70.5669.86175.5683.3791.72113.51
332.14177.07200.6774.2570.5724.81
000000
0.020.083.690.020.020.02
0.460.364.090.20.20.21
3.33.4701.331.311.31
274.1181.24135.12104.3860.5648.58
4035.576.730.853.556.14
3.623.690.141.431.381.36
4.084.044.231.631.581.57
5.233.672.321.831.591.58
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Advanz Pharma Corp provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Advanz Pharma Corp's financial health and stability.

Assets

Advanz Pharma Corp's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Advanz Pharma Corp must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Advanz Pharma Corp after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Advanz Pharma Corp's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (B)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201520162017201820192020
-0.03-1.31-1.591.47-0.2-0.07
76184228252206195
000000
-83-14242-13-45
0.161.551.62-1.580.190.09
4225129413310791
00-4000
122408283141188166
-2-1-2-4-5-5
-3,799-310-1-34-159
-3,797-2912-28-153
000000
3.270.33-0.06-0.03-0.02-0.02
8110058700
3.8-0.09-0.37-0.22-0.13-0.11
-276.00-415.00-315.00-784.00-107.00-91.00
-10-110000
112242-70-10236-100
000000
000000

Advanz Pharma Corp stock margins

The Advanz Pharma Corp margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Advanz Pharma Corp. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Advanz Pharma Corp.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Advanz Pharma Corp's sales revenue. A higher gross margin percentage indicates that the Advanz Pharma Corp retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Advanz Pharma Corp's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Advanz Pharma Corp's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Advanz Pharma Corp's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Advanz Pharma Corp. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Advanz Pharma Corp's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Advanz Pharma Corp Margin History

Advanz Pharma Corp Gross marginAdvanz Pharma Corp Profit marginAdvanz Pharma Corp EBIT marginAdvanz Pharma Corp Profit margin
2021e63.41 %0 %-3,854.42 %
202063.41 %5.66 %-14.24 %
201966.26 %4.54 %-38.56 %
201867.25 %-0.81 %273.25 %
201769.56 %12.46 %-254.04 %
201672.9 %28.33 %-161.21 %
201576.08 %35.06 %-8.01 %

Advanz Pharma Corp Stock Sales Revenue, EBIT, Earnings per Share

The Advanz Pharma Corp earnings per share therefore indicates how much revenue Advanz Pharma Corp has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Advanz Pharma Corp earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Advanz Pharma Corp's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Advanz Pharma Corp’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Advanz Pharma Corp's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Advanz Pharma Corp Revenue, EBIT and net profit per share

DateAdvanz Pharma Corp Sales per ShareAdvanz Pharma Corp EBIT per shareAdvanz Pharma Corp Earnings per Share
2021e8.22 undefined0 undefined-317 undefined
202010.75 undefined0.61 undefined-1.53 undefined
201910.39 undefined0.47 undefined-4.01 undefined
201834.29 undefined-0.28 undefined93.69 undefined
20173,672.12 undefined457.43 undefined-9,328.73 undefined
20164,798.68 undefined1,359.48 undefined-7,735.74 undefined
20153,268.58 undefined1,146 undefined-261.74 undefined

Advanz Pharma Corp business model

Advanz Pharma Corp Ltd is an international pharmaceutical company that focuses on the development, manufacturing, and marketing of generics and specialty pharmaceuticals. The company is headquartered in London and operates numerous subsidiaries worldwide. Answer: Advanz Pharma Corp Ltd is an international pharmaceutical company that specializes in developing, manufacturing, and marketing generics and specialty pharmaceuticals. It was founded in 2015 through the merger of two well-known generic drug manufacturers: Canadian company Concordia International Corp and Irish company Warner Chilcott plc. Advanz Pharma is listed on the Bombay Stock Exchange and the National Stock Exchange of India since 2017. Answer: Advanz Pharma has its own business model that emphasizes the marketing and development of generics and specialty pharmaceuticals. The company focuses on providing cost-effective medical solutions by producing generic versions of products whose patent has expired or is about to expire. These medications are typically more affordable than their original counterparts. However, the company also manufactures specialty pharmaceuticals that specialize in rare diseases, oncology, and hormonal disorders. Answer: Advanz Pharma is divided into several divisions to produce various types of medications, such as: - Cardiology - Oncology - Gastroenterology - Neurology - Antibiotics - Diabetic care - Endocrinology and reproduction Answer: Advanz Pharma manufactures a wide range of generics and specialty pharmaceuticals. Some of the products include: - Metformin, an antidiabetic medication - Carbidopa/levodopa, a medication for treating Parkinson's disease - Ezetimibe, for lowering cholesterol levels - Doxorubicin, a cancer medication - Hydroxyzine, an antiallergic medication - Methotrexate, a cancer and rheumatoid arthritis medication Answer: In conclusion, Advanz Pharma Corp Ltd is an international generics and specialty pharmaceutical company that focuses on the development, manufacturing, and marketing of cost-effective medications. The company has a broad product portfolio that includes both generics and specialized medications. It aims to provide cost-effective solutions to improve access to essential healthcare. Advanz Pharma Corp is one of the most popular companies on Eulerpool.com.

Advanz Pharma Corp SWOT Analysis

Strengths

Advanz Pharma Corp Ltd has a strong global presence with operations in multiple countries.

The company has a diverse product portfolio, including a wide range of specialty pharmaceuticals.

Advanz Pharma Corp Ltd has a robust research and development pipeline, allowing for continuous innovation and product development.

Weaknesses

The company heavily relies on a few key suppliers, which may pose supply chain risks.

Advanz Pharma Corp Ltd faces increasing competition in the pharmaceutical industry, which may impact market share and profitability.

The company has had instances of regulatory non-compliance, resulting in penalties and reputational damage.

Opportunities

The growing demand for specialty pharmaceuticals presents a significant opportunity for Advanz Pharma Corp Ltd to expand its market share.

Advanz Pharma Corp Ltd can explore potential partnerships and collaborations to enhance its research and development capabilities.

The company can leverage advancements in technology to improve manufacturing processes and increase efficiency.

Threats

Regulatory changes and stricter compliance requirements pose a threat to Advanz Pharma Corp Ltd's operations.

The global economic and political uncertainties may impact the company's financial performance and growth strategy.

The emergence of generic substitutes for the company's specialty pharmaceuticals presents a threat to market share.

Advanz Pharma Corp Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Advanz Pharma Corp historical P/E ratio, EBIT multiple, and P/S ratio

Advanz Pharma Corp shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Advanz Pharma Corp earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Advanz Pharma Corp's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Advanz Pharma Corp’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Advanz Pharma Corp's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Advanz Pharma Corp dividend payout ratio

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Advanz Pharma Corp represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Advanz Pharma Corp could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Advanz Pharma Corp's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Advanz Pharma Corp Payout Ratio History

DateAdvanz Pharma Corp Payout ratio
2021e0 %
20200 %
20190 %
20180 %
20170 %
2016-0.87 %
2015-34.39 %
Unfortunately, there are currently no price targets and forecasts available for Advanz Pharma Corp.

Most common questions regarding Advanz Pharma Corp

What values and corporate philosophy does Advanz Pharma Corp represent?

Advanz Pharma Corp Ltd showcases a strong commitment to its values and corporate philosophy. The company believes in fostering innovation, promoting patient-centricity, and delivering high-quality healthcare products. Advanz Pharma Corp Ltd is focused on maximizing patient access to essential medicines, prioritizing research and development, and maintaining robust ethical standards. With an unwavering dedication to integrity and excellence, Advanz Pharma Corp Ltd continuously strives to improve the lives of individuals worldwide through its exceptional pharmaceutical solutions.

In which countries and regions is Advanz Pharma Corp primarily present?

Advanz Pharma Corp Ltd is primarily present in several key countries and regions globally. The company has a significant presence and operations in countries like the United States, Canada, United Kingdom, Germany, France, Spain, Italy, Australia, and New Zealand. Additionally, Advanz Pharma Corp Ltd has a strong market presence in various regions across Asia, including India, China, Japan, and South Korea. With a diverse presence across multiple countries and regions, the company leverages its global footprint to deliver high-quality pharmaceutical products and solutions to patients around the world.

What significant milestones has the company Advanz Pharma Corp achieved?

Advanz Pharma Corp Ltd has achieved several significant milestones. Firstly, the company successfully expanded its global footprint by establishing a strong presence in more than 90 countries. Secondly, Advanz Pharma Corp Ltd received numerous regulatory approvals for its high-quality and affordable generic pharmaceutical products, enhancing accessibility to healthcare worldwide. Additionally, the company consistently focuses on research and development, leading to the introduction of innovative therapies and treatment options. Furthermore, Advanz Pharma Corp Ltd has demonstrated strong financial growth and stability, with consistent revenue generation and shareholder value creation. These milestones highlight Advanz Pharma Corp Ltd's commitment to making a positive impact on global healthcare by delivering high-quality and cost-effective pharmaceutical solutions.

What is the history and background of the company Advanz Pharma Corp?

Advanz Pharma Corp Ltd is a renowned pharmaceutical company with a rich history and significant background. Established in [year], Advanz Pharma has continuously evolved over the years to become a leader in the pharmaceutical industry. With a focus on innovation, quality, and customer satisfaction, the company has a proven track record of delivering high-quality products and services. Advanz Pharma's commitment to research, development, and growth has propelled them to the forefront of the industry. With a global presence and a dedicated team of professionals, Advanz Pharma Corp Ltd is dedicated to improving healthcare outcomes and enhancing the quality of life for patients worldwide.

Who are the main competitors of Advanz Pharma Corp in the market?

The main competitors of Advanz Pharma Corp Ltd in the market include leading pharmaceutical companies such as Pfizer, Novartis, Johnson & Johnson, and GlaxoSmithKline. These companies are renowned for their strong presence and global reach in the pharmaceutical industry. As Advanz Pharma Corp Ltd operates in this competitive market, it strives to differentiate itself through its unique product offerings, advanced research and development, and strategic partnerships. With its innovative approach and dedication to providing high-quality healthcare solutions, Advanz Pharma Corp Ltd continues to compete with its esteemed counterparts in the pharmaceutical sector.

In which industries is Advanz Pharma Corp primarily active?

Advanz Pharma Corp Ltd is primarily active in the pharmaceutical industry.

What is the business model of Advanz Pharma Corp?

The business model of Advanz Pharma Corp Ltd focuses on the development, manufacturing, and distribution of specialty pharmaceutical products. The company primarily operates in the global generic and specialty pharmaceutical markets. Advanz Pharma Corp Ltd is committed to providing affordable and high-quality medicines to patients worldwide. With a wide range of products, it aims to address diverse therapeutic areas such as central nervous system disorders, oncology, and cardiovascular diseases. Through its strategic partnerships, Advanz Pharma Corp Ltd ensures a robust supply chain and maintains a strong global presence in the pharmaceutical industry.

What is the P/E ratio of Advanz Pharma Corp 2024?

The P/E ratio cannot be calculated for Advanz Pharma Corp at the moment.

What is the P/S ratio of Advanz Pharma Corp 2024?

The P/S cannot be calculated for Advanz Pharma Corp currently.

What is the Quality Investing of Advanz Pharma Corp?

The Quality Investing cannot be calculated for Advanz Pharma Corp at the moment.

What is the revenue of Advanz Pharma Corp 2024?

The revenue cannot currently be calculated for Advanz Pharma Corp.

How high is the profit of Advanz Pharma Corp 2024?

The profit cannot currently be calculated for Advanz Pharma Corp.

What is the business model of Advanz Pharma Corp

Advanz Pharma Corp Ltd is a global healthcare company specializing in the development and marketing of generic and specialized pharmaceutical products. The company operates in various business sectors and pursues a diversified business model to strengthen its position as one of the leading players in the pharmaceutical products industry.

What is the Advanz Pharma Corp dividend?

Advanz Pharma Corp pays a dividend of 0 USD distributed over payouts per year.

How often does Advanz Pharma Corp pay dividends?

The dividend cannot currently be calculated for Advanz Pharma Corp or the company does not pay out a dividend.

What is the Advanz Pharma Corp ISIN?

The ISIN of Advanz Pharma Corp is JE00BJVH6L55.

What is the Advanz Pharma Corp WKN?

The WKN of Advanz Pharma Corp is A2PYQF.

What is the Advanz Pharma Corp ticker?

The ticker of Advanz Pharma Corp is CXRXF.

How much dividend does Advanz Pharma Corp pay?

Over the past 12 months, Advanz Pharma Corp paid a dividend of 67.5 USD . This corresponds to a dividend yield of about 395.66 %. For the coming 12 months, Advanz Pharma Corp is expected to pay a dividend of 0 USD.

What is the dividend yield of Advanz Pharma Corp?

The current dividend yield of Advanz Pharma Corp is 395.66 %.

When does Advanz Pharma Corp pay dividends?

Advanz Pharma Corp pays a quarterly dividend. This is distributed in the months of November, February, May, August.

How secure is the dividend of Advanz Pharma Corp?

Advanz Pharma Corp paid dividends every year for the past 0 years.

What is the dividend of Advanz Pharma Corp?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Advanz Pharma Corp located?

Advanz Pharma Corp is assigned to the 'Health' sector.

Wann musste ich die Aktien von Advanz Pharma Corp kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Advanz Pharma Corp from 7/29/2016 amounting to 0.075 USD, you needed to have the stock in your portfolio before the ex-date on 7/13/2016.

When did Advanz Pharma Corp pay the last dividend?

The last dividend was paid out on 7/29/2016.

What was the dividend of Advanz Pharma Corp in the year 2023?

In the year 2023, Advanz Pharma Corp distributed 0 USD as dividends.

In which currency does Advanz Pharma Corp pay out the dividend?

The dividends of Advanz Pharma Corp are distributed in USD.

All fundamentals about Advanz Pharma Corp

Our stock analysis for Advanz Pharma Corp Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Advanz Pharma Corp Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.